Cholera Toxin and Its B Subunit Promote Dendritic Cell Vaccination with Different Influences on Th1 and Th2 Development
Kristina Eriksson
Infection and Immunity, 2003
View PDFchevron_right
CTA1-DD-Immune Stimulating Complexes: a Novel, Rationally Designed Combined Mucosal Vaccine Adjuvant Effective with Nanogram Doses of Antigen
Peter Kaastrup
The Journal of Immunology, 2001
View PDFchevron_right
The combined CTA1-DD/ISCOM adjuvant vector promotes priming of mucosal and systemic immunity to incorporated antigens by specific targeting of B cells
Karin Lovgren
The Journal of …, 2006
View PDFchevron_right
Dendritic Cell-Mediated Induction of Mucosal Cytotoxic Responses following Intravaginal Immunization with the Nontoxic B Subunit of Cholera Toxin
Cecil Czerkinsky
The Journal of Immunology, 2006
View PDFchevron_right
Splenic Marginal Zone Dendritic Cells Mediate the Cholera Toxin Adjuvant Effect: Dependence on the ADP-Ribosyltransferase Activity of the Holotoxin
Karl-eric Magnusson
The Journal of Immunology, 2005
View PDFchevron_right
Transcutaneous Immunization with Cholera Toxin B Subunit Adjuvant Suppresses IgE Antibody Responses Via Selective Induction of Th1 Immune Responses
Cecil Czerkinsky
The Journal of Immunology, 2003
View PDFchevron_right
The ADP-ribosylating CTA1-DD adjuvant enhances T cell-dependent and independent responses by direct action on B cells involving anti-apoptotic Bcl-2-and …
Nils Lycke
The Journal of …, 2000
View PDFchevron_right
The B cell targeted adjuvant, CTA1-DD, exhibits potent mucosal immunoenhancing activity despite pre-existing anti-toxin immunity
Nils Lycke
Vaccine, 2001
View PDFchevron_right
New prospects for mucosal immunization: anti-infectious and anti-inflammatory vaccines
Cecil Czerkinsky
Research in Immunology, 1998
View PDFchevron_right
Coupling of antigen to cholera toxin for dendritic cell vaccination promotes the induction of MHC class I-restricted cytotoxic T cells and the rejection of a cognate antigen-expressing model tumor
Kristina Eriksson
European Journal of Immunology, 2004
View PDFchevron_right
The role of ADP-ribosylation and GM1-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin
Lolke de Haan
Immunology and Cell Biology, 1998
View PDFchevron_right
In Vivo Adjuvant-Induced Mobilization and Maturation of Gut Dendritic Cells after Oral Administration of Cholera Toxin
Cecil Czerkinsky
The Journal of Immunology, 2004
View PDFchevron_right
Cholera Toxin B Subunit as a Carrier Molecule Promotes Antigen Presentation and Increases CD40 and CD86 Expression on Antigen-Presenting Cells
Kristina Eriksson
Infection and Immunity, 2001
View PDFchevron_right
Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa
Bruno Goddeeris
Veterinary Research, 2006
View PDFchevron_right
Effects of the adjuvant cholera toxin on dendritic cells: stimulatory and inhibitory signals that result in the amplification of immune responses
Antonella Riccomi
International Journal of Medical Microbiology, 2001
View PDFchevron_right
Polyclonal Treg cells enhance the activity of a mucosal adjuvant
Antonella Riccomi
Immunology & Cell Biology, 2010
View PDFchevron_right
Vaccine Antigens Responses to Nasally Administered as an Adjuvant for Mucosal Immune
Alexandra Duverger
View PDFchevron_right
Ganglioside GM1 Binding Peptides: A Potential Adjuvant for Transcutaneous Immunization
James Tong
The Open Immunology Journal, 2009
View PDFchevron_right
Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8+ T cell population in different tissues
Lea Eisenbach
Vaccine, 2004
View PDFchevron_right
Critical Role for Activation of Antigen-Presenting Cells in Priming of Cytotoxic T Cell Responses After Vaccination with Virus-Like Particles
Martin Bachmann
The Journal of Immunology, 2002
View PDFchevron_right
CD11chigh Dendritic Cells Are Essential for Activation of CD4+ T Cells and Generation of Specific Antibodies following Mucosal Immunization
Tobias Hedberg
The Journal of Immunology, 2009
View PDFchevron_right
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants
Giuseppe Giudice
Vaccine, 2001
View PDFchevron_right
Chimeras of Labile Toxin One and Cholera Toxin Retain Mucosal Adjuvanticity and Direct Th Cell Subsets Via Their B Subunit
Prosper Boyaka
The Journal of Immunology, 2003
View PDFchevron_right
B and Th cell response to Ag in vivo: Implications for vaccine development and diseases
Irina Grigorova
Immunological Reviews, 2020
View PDFchevron_right
Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins, Subunits, and Unrelated Adjuvants
Gary Matyas
Infection and Immunity, 2000
View PDFchevron_right
Strong Differential Regulation of Serum and Mucosal IgA Responses as Revealed in CD28-Deficient Mice Using Cholera Toxin Adjuvant
Tomas Leanderson
The Journal of Immunology, 2003
View PDFchevron_right
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA
Cecil Czerkinsky
Expert Review of Vaccines, 2003
View PDFchevron_right
Evidence for a role of ganglioside GM1 in antigen presentation: binding enhances presentation of Escherichia coli enterotoxin B subunit (EtxB) to CD4+ T cells
Richard Mitchell
International Immunology, 2001
View PDFchevron_right
Understanding Mechanisms of Actions for Vaccine Adjuvants Critical for Designing Effective Vaccines: A narrative review
Moses Sichangi
2020
View PDFchevron_right
Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues
Jerry McGhee
The Journal of Immunology, 2000
View PDFchevron_right
Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue
Yasushi Itoh
Infection and immunity, 1998
View PDFchevron_right
Binding to gangliosides containing N-acetylneuraminic acid is sufficient to mediate the immunomodulatory properties of the nontoxic mucosal adjuvant LT-IIb (T13I)
T. Connell
2010
View PDFchevron_right
Novel Vaccine Adjuvants
Owais Mohammad
BioMed Research International, 2013
View PDFchevron_right
Optimization of epicutaneous immunization for the induction of CTL
Yuxiang Hu
Vaccine, 2003
View PDFchevron_right